News >

Optimal AE Management Required With Immunotherapy in Melanoma

Brittany Cote
Published: Friday, Jan 17, 2020

Kathleen Madden, RN, MSN, FNP-BC, AOCNP, APHN, a nurse practitioner at NYU Langone Health's Perlmutter Cancer Center

Kathleen Madden, FNP, MSN, AOCNP, APHN, APHN

Being able to quickly detect and properly manage adverse events (AEs) that arise in patients with melanoma who are receiving immunotherapy is key to improving their experience with treatment, explained Kathleen Madden, FNP, MSN, AOCNP, APHN.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication